Articles

Results 1 to 4 of 4
Most popular |Most recent


‘Darunavir’ CJEU referral withdrawn - Article 3(a) of the SPC Regulation

United Kingdom, European Union - December 20 2019 At the end of September, we reported here on the publication of AG Hogan’s Opinion on the joint referrals from the German Bundespatentgericht (case...

Tom Errington.

SPC Double Whammy - Interpreting Article 3(a) of the SPC Regulation

United Kingdom, European Union, Germany - September 13 2019 At the end of June, the CJEU heard the joint referrals from the German Bundespatentgericht (case C-65017) for Merck’s sitagliptin product and from...

Charles Kerrigan.

EPO's strict approach to deciding if a composition can benefit from medical use protection - EPO Technical Board of Appeal decision; T 213615

United Kingdom, European Union - May 30 2019 The EPO Technical Board of Appeal (TBA) reviewed the law around novelty of use, and determined that in the case of CardioPolymer, Inc.'s European...

Jane Hollywood.

Judgment on Abraxis C-44317; 21st March 2019

United Kingdom, European Union - March 21 2019 The CJEU delivered its judgment last week on the case of Abraxis v Comptroller General of Patents concerning Supplementary Protection Certificates...

Robert Stephen.